- Home
- HUM vs VYLR Comparison
HUM vs VYLR Comparison
Compare HUM & VYLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HUM | VYLR |
|---|---|---|
| Founded | 1961 | 1802 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.3B | 52.2B |
| IPO Year | 2002 | 2026 |
Fundamental Metrics
Financial Performance| Metric | HUM | VYLR |
|---|---|---|
| Price | $416.72 | $73.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 26 | 16 |
| Target Price | ★ $465.13 | $82.07 |
| AVG Volume (30 Days) | 1.2M | ★ 4.6M |
| Earning Date | 11-06-2026 | 11-11-2026 |
| Dividend Yield | ★ 0.84% | 0.70% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 9.83 | N/A |
| Revenue | ★ $129,664,000,000.00 | N/A |
| Revenue This Year | $25.51 | N/A |
| Revenue Next Year | $3.65 | $3.80 |
| P/E Ratio | $42.73 | ★ N/A |
| Revenue Growth | ★ 10.11 | N/A |
| 52 Week Low | $163.11 | $65.11 |
| 52 Week High | $456.50 | $77.39 |
Technical Indicators
Market Signals| Indicator | HUM | VYLR |
|---|---|---|
| Relative Strength Index (RSI) | 53.46 | 63.56 |
| Support Level | $407.50 | $71.20 |
| Resistance Level | $419.36 | $76.13 |
| Average True Range (ATR) | 16.26 | 2.84 |
| MACD | -0.26 | -0.14 |
| Stochastic Oscillator | 49.74 | 46.23 |
Price Performance
Historical ComparisonAbout HUM Humana Inc.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
About VYLR Vylor Inc. Common Stock
Vylor is a seed and crop genetics pure-play company. The company was formed in 2026 when it was spun off from Corteva. Vylor is a leader in the development of genetically modified seeds and other advanced germplasm and traits that boost crop yields. The company operates in two segments based on geography—Americas and Rest of World. The Americas segment, which includes North and South America, generates most sales and profits.